Trials / Sponsors / Aspireo Pharmaceuticals Limited
Aspireo Pharmaceuticals Limited
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics Acromegaly | Phase 2 | 2013-11-01 |
| Completed | Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients. Acromegaly | Phase 2 | 2012-10-01 |
| Completed | Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173 Healthy | Phase 1 | 2012-04-01 |
| Completed | Single Ascending Dose Tolerability Study of DG3173 Healthy | Phase 1 | 2008-05-01 |
| Completed | Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173 Healthy | Phase 1 | — |